BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24917602)

  • 1. For patients with chronic asthma not controlled with inhaled corticosteroids alone, long-acting β-agonists are associated with fewer exacerbations than leukotriene receptor agonists.
    Colice G
    Evid Based Med; 2014 Oct; 19(5):174. PubMed ID: 24917602
    [No Abstract]   [Full Text] [Related]  

  • 2. [PHARMACOGENETIC MARKERS OF THE EFFECTIVENESS OF TREATMENT OF CHILDREN WITH ATOPIC BRONCHIAL ASTHMA.].
    Balabolkin II; Bulgakova VA
    Eksp Klin Farmakol; 2016; 79(11):35-40. PubMed ID: 29791107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.
    Sin DD; Man J; Sharpe H; Gan WQ; Man SF
    JAMA; 2004 Jul; 292(3):367-76. PubMed ID: 15265853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic interventions to reduce the risk of asthma exacerbations.
    O'Byrne PM
    Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
    Currie GP; Lee DK; Menzies D; Lipworth BJ
    Chest; 2006 Jul; 130(1):301-2. PubMed ID: 16840420
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.
    Murray CS; Thomas M; Richardson K; Price DB; Turner SW
    J Allergy Clin Immunol Pract; 2017; 5(4):1082-1090.e7. PubMed ID: 28351789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of bronchial asthma.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
    Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
    J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies.
    Albers FC; Price RG; Smith SG; Yancey SW
    J Allergy Clin Immunol; 2017 Nov; 140(5):1464-1466.e4. PubMed ID: 28687231
    [No Abstract]   [Full Text] [Related]  

  • 11. Principal findings of systematic reviews of acute asthma treatment in childhood.
    Castro-Rodriguez JA; J Rodrigo G; E Rodríguez-Martínez C
    J Asthma; 2015; 52(10):1038-45. PubMed ID: 26303207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies to reduce asthma exacerbations.
    O'Byrne PM
    J Allergy Clin Immunol; 2011 Aug; 128(2):257-63; quiz 264-5. PubMed ID: 21531015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.
    Buhl R; Farmer SG
    Proc Am Thorac Soc; 2004; 1(2):136-42. PubMed ID: 16113426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black clouds and black boxes: comment on "Long-acting β2-agonist step-off in patients with controlled asthma".
    Chan CM; Shorr AF
    Arch Intern Med; 2012 Oct; 172(18):1375-6. PubMed ID: 22928180
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
    O'Byrne PM; Gauvreau GM; Murphy DM
    J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do "real life" studies tell us about asthma controllers?
    Williams PV
    J Allergy Clin Immunol Pract; 2014; 2(5):614-5. PubMed ID: 25213057
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination therapy: addition of other long-term-control medications to inhaled corticosteroids.
    National Asthma Education and Prevention Program
    J Allergy Clin Immunol; 2002 Nov; 110(5 Suppl):S169-80. PubMed ID: 12518558
    [No Abstract]   [Full Text] [Related]  

  • 19. New combination therapies for asthma.
    Donohue JF; Ohar JA
    Curr Opin Pulm Med; 2001 Mar; 7(2):62-8. PubMed ID: 11224725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention of exercise-induced bronchoconstriction: what are the options?
    Anderson SD
    Expert Rev Respir Med; 2012 Aug; 6(4):355-7. PubMed ID: 22971059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.